Alvotech (ALVO) Beginning Cash Balance (2022 - 2024)

Alvotech (ALVO) reported Beginning Cash Balance of -$9.5 million for Q4 2024, up 81.0% quarter-over-quarter from -$50.0 million in Q4 2022.

Alvotech (ALVO) Beginning Cash Balance (2022 - 2024) Analysis & Trends

Alvotech has reported Beginning Cash Balance for 2 years, with the latest figure at -$9.5 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.97 Bn	36.23 Bn	1.97 Bn
2	Zoetis	33.59 Bn	31.65 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Neurocrine Biosciences	16.10 Bn	14.78 Bn	800.70 Mn
5	Aurora Cannabis	15.56 Bn	15.47 Bn	21.72 Mn
6	Elanco Animal Health	12.04 Bn	11.61 Bn	785.00 Mn
7	Alkermes	7.36 Bn	6.84 Bn	-116.06 Mn
8	Lantheus Holdings	6.74 Bn	6.24 Bn	230.92 Mn
9	Liquidia	6.27 Bn	6.04 Bn	121.79 Mn
10	Alvotech	12.24 Mn	-160.12 Mn	-22.39 Mn

Download Data